Corestemchemon, Inc.
Corestemchemon, Inc.
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluate the Safety and Tolerability of CE211NS21 in Patients With AQP4-IgG-positive NMOSD Relapse | Neuromyelitis Optica Spectrum Disorder Relapse | Not yet recruiting | Phase 1 | 2026-05-19 | NCT07595965 |